Current Issue - July 2016, Volume 10, Issue No. 2

1. Luyten F, Dell'accio F, De Bari C. Skeletal Tissue Engineering: Opportunities and Challenges. Best Pract Res Clin Rheumatol. (2008); 15: 7 59-69.
2. Flanigan DC, Harris JD, Trinh TQ, Siston RA, Brophy RH, et al. Prevalence of Chondral Defects in Athlete’s Knees A Systematic Review. Med Sci Sports Exerc. 2010; 42: 795-801.
3. Management of Osteoarthritis 2nd ed. Clinical Practice Guidelines (2013)
4. Zhang Y, Jordan JM. Epidemiology of Osteoarthritis, Clin Geriatr Med. 2010; 26: 355-69.
5. Zhu YM, Yuan MH, Meng HY, Wang AY, Guo QY, Wang Y, et al. Basic Science and Clinical Application of Platelet Rich Plasma for Cartilage Defect and Osteoarthritis: A review. Osteoarthritis Cartilage. 2013; 21: 1627-37.
6. Narayanan SS, Suhail A, Harjeet S, Shahril Y, Masbah O. Efficacy of Intra - Articular Injection of Hyaluronic Acid in Treatment of Knee Osteoarthritis Mal Orthop J. 2009; 3(1): 19-23.
7. Altman R, Asch E, Bloch D. Development of Criteria for the Classification and Reporting of Osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986; 29(8): 1039-49.
8. Zhang W, Doherty W, Peat G, MA Bierma-Zeinstra, NK Arden, B Bresnihan, G Herrero-Beaumont, et al. EULAR Evidence-Based Recommendations for the Diagnosis of Knee Osteoarthritis. Ann Rheum Dis. 2010; 69(3): 483-9.
9. Hart LE. Long-term Effect of Glucosamine Sulfate on Progression of Knee Osteoarthritis. Clin J Sport Med. 2002; 12(2): 134 -5.
10. Simon L.S. Osteoarthritis. Curr Rheumatol Rep. 1999; 1(1): 45-7.
11. Hardingham T, Tew S, Murdoch A. Tissue engineering: Chondrocytes and Cartilage. Arthritis Research. 2002; 4(3): 63 - 8.
12. Altman RD, Hochberg MC, Moskowitz RW, Schnitzer TJ. Recommendation for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum. 2000; 43(9): 1905-15.
13. Bellamy NC, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Viscosupplementation for the Treatment of Osteoarthritis of the Knee. Cochrane Database Syst Rev. 2006; 2: 5321.
14. Grace H, Michael L, Timothy M, et al. Intra-articular Hyaluronic Acid in Treatment of knee Osteoarthritis: A Meta-analysis. JAMA. 2003; 290: 3115- 21.
15. Yoga R, Mukaram M, Ramachandran. Hyaluronate for the Treatment of Osteoarthritis of the Knee: A Retrospective Review of 45 Patients. Mal J Orthop. 2009; 3: 4-7.
16. Guidolin DD, Ronchetti IP, Guerra D, Frizziero L. Morphological Analysis of Articular Cartilage Biopsies: Randomized, Clinical Study Comparing the Effects of 500-730 kDa Sodium Hyaluronate (Hyalgan) and Methylprednisolone Acetate on Primary Osteoarthritis of the Knee. Journal of Physician. 2004; 50: 249-56.
17. Meloni F, Milia F, Cavazzuti M, Doria C, Lisai P, Profili S. Clinical Evaluation of Sodium Hyaluronate in the Treatment of Patients with Supraspinatus Tendinosis under Echographic Guide: Experimental Study of Periarticular Injections. Eurp J Radiol. 2008; 68(1):170-3.
18. Spakova T, Rosocha J, Lacko M, Harvanova D, Gharaibeh A, et al. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012; 91(5):411-7.
19. Wu CC, Chen WH, Zao B, Lai PL, Lin TC, Lo HY, et al. Regenerative Potentials of Platelet-Rich Plasma Enhanced by Collagen in Retrieving Pro-inflammatory Cytokine-inhibited Chondrogenesis. J Biomaterials. 2011; 32: 5847-54.
20. Broggini N, Hofstetter W, Hunziker E, Bosshardt DD, Bornstein MM, Seto I, et al. The influence of PRP on Early Bone Formation in Membrane Protected Defects: A Histological and Histomorphometric Study in The Rabbit Calvaria Clin Implant Dent Relat Res. 2011; 11: 11-2.
21. Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E. Platelets and wound healing. Front Biosci. 2008; 13: 3532-48.
22. Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-Rich Plasma: A Milieu of Bioactive Factors. Arthroscopy. 2012; 28: 429-39.
23. Anitua E, Sanchez M, De la Fuente M, Zalduendo MM, Orive G. Plasma rich in growth factors stimulates tendon and synovial fibroblast migration and biological properties of HA. Knee Surg Sports Traumatol Arthrosc. 2012; 20: 1657-65.
24. Higgins MD, Taylor MK, Park D. Reliability and validity of the International Knee Documentation Committee (IKDC) Subjective Knee Form. J Bone Joint Spine. 2007; 74(6): 594-99.
25. Kon E, Mandelbaum B, Buda R, Filardo G, Delcogliano M, Timoncini A, et al. Platelet-Rich Plasma Intra-Articular Injection Versus Hyaluronic Acid Viscosupplementation as Treatments for Cartilage Pathology: From Early Degeneration to Osteoarthritis. Arthroscopy. 2011; 27(11): 1490-501.
26. Berenbaum F, Grifka J, Cazzaniga S, D'Amato M, Giacovelli G, et al.A randomized double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis. Ann Rheum Dis. 2012; 71(9): 1454-60.
27. Wang CT, Lin YT, Hou SM. High Molecular Weight Hyaluronic Acid Down Regulates The Gene Expression of Osteoarthritis Associated Cytokines and Enzymes in Fibroblast Like Synoviocytes From Patients With Early Osteoarthritis, Osteoarthritis Cartilage. 2006; 14(12): 1237-47.
28. Knudson CB, Knudson W. Hyaluronan and CD44: modulators of chondrocyte metabolism. Clin Orthop Relat Res. 2004; (427): 152-62.
29. Nagano O, Sata H. Mechanism and biological significance of CD44 cleavage. Cancer Sci. 2004; 95(12): 930-5.
30. Cerza F, Carni S, Carcangiu A, Di Vavo I, Schiavilla V, Pecora A, et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med. 2012; 40: 2822- 7.

Abstract   |   Reference